Author:
Wenzel Carina,Herold Sylvia,Wermke Martin,Aust Daniela E.,Baretton Gustavo B.
Publisher
Deutscher Arzte-Verlag GmbH
Reference59 articles.
1. Thomas R, Buettner R, Wolf JA: Genomics-based classification of human lung tumors. Sci Transl Med 2013; 5: 209ra153
2. Lombardo R, Tosi F, Nocerino A, et al.: The quest for improving treatment of cancer of unknown primary (CUP) through molecularly-driven treatments: a systematic review. Front Oncol 2020; 10: 533 CrossRef
3. AWMF: S3-Leitlinie Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms 2018. https://www.awmf.org/uploads/tx_szleitlinien/020-007OL_l_S3_Lungenkarzinom_2018-03.pdf (last accessed on 16 February 2021).
4. Soria JC, Ohe Y, Vansteenkiste J, et al.: Osimertinib in untreated EGFR-mutated advanced non–small-cell lung cancer. N Engl J Med 2018; 378: 113–25
5. Solomon BJ, Mok T, Kim DW, et al.: First-line crizotinib versus chemotherapy in ALK-positive lung cancer. N Engl J Med 2014; 371: 2167–77
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献